주요국의 의약품 급여관리를 위한 수평탐색 현황 비교
With the recent development of innovative medical technology, the market entry of high-priced drugs, such as Kymriah, Zolgensma, and Luxturna injections, is increasing. Accordingly, there is a growing need to effectively manage benefits by reviewing the characteristics of drugs, significant adverse...
Saved in:
| Published in | HIRA Research Vol. 4; no. 1; pp. 20 - 33 |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | Korean |
| Published |
건강보험심사평가원 심사평가정책연구소
31.05.2024
건강보험심사평가원 |
| Subjects | |
| Online Access | Get full text |
| ISSN | 2765-6764 2765-7353 |
| DOI | 10.52937/hira.24.4.1.e6 |
Cover
| Abstract | With the recent development of innovative medical technology, the market entry of high-priced drugs, such as Kymriah, Zolgensma, and Luxturna injections, is increasing. Accordingly, there is a growing need to effectively manage benefits by reviewing the characteristics of drugs, significant adverse reactions, and treatment effects in advance through horizon scanning. This study conducts a literature review of the status and methodology of domestic and foreign horizon scanning and proposes horizon scanning methods for pharmaceutical benefits management. The review results indicate that horizon scanning in Europe had different operational plans, such as the scope and duration of the search by country. However, the implementation typically aimed to reflect horizon scanning in policy decisions, such as determining benefits directions or establishing a regulatory agency management plan. Meanwhile, the results of horizon scanning in the United States and Korea were provided as reference materials to major stakeholders rather than directly reflecting them in the policy. Although listing high-priced drugs with uncertain long-term treatment effects and financial impact is expected to increase, periodic horizon scanning activities for pharmaceutical benefits management have not been conducted in Korea. Therefore, as a horizon scanning procedure for pharmaceutical benefits management, this study proposes the following four steps, namely, (step 1) define target indications and drug efficacy groups; (step 2) establish the purpose of horizon scanning; (step 3) review the extant literature; (step 4) summarize and discuss the results; (step 5) deliberate potential decision-making. |
|---|---|
| AbstractList | With the recent development of innovative medical technology, the market entry of high-priced drugs, such as Kymriah, Zolgensma, and Luxturna injections, is increasing. Accordingly, there is a growing need to effectively manage benefits by reviewing the characteristics of drugs, significant adverse reactions, and treatment effects in advance through horizon scanning. This study conducts a literature review of the status and methodology of domestic and foreign horizon scanning and proposes horizon scanning methods for pharmaceutical benefits management. The review results indicate that horizon scanning in Europe had different operational plans, such as the scope and duration of the search by country. However, the implementation typically aimed to reflect horizon scanning in policy decisions, such as determining benefits directions or establishing a regulatory agency management plan. Meanwhile, the results of horizon scanning in the United States and Korea were provided as reference materials to major stakeholders rather than directly reflecting them in the policy. Although listing high-priced drugs with uncertain long-term treatment effects and financial impact is expected to increase, periodic horizon scanning activities for pharmaceutical benefits management have not been conducted in Korea. Therefore, as a horizon scanning procedure for pharmaceutical benefits management, this study proposes the following four steps, namely, (step 1) define target indications and drug efficacy groups; (step 2) establish the purpose of horizon scanning; (step 3) review the extant literature; (step 4) summarize and discuss the results; (step 5) deliberate potential decision-making. With the recent development of innovative medical technology, the market entry of high-priced drugs, such as Kymriah, Zolgensma, and Luxturna injections, is increasing. Accordingly, there is a growing need to effectively manage benefits by reviewing the characteristics of drugs, significant adverse reactions, and treatment effects in advance through horizon scanning. This study conducts a literature review of the status and methodology of domestic and foreign horizon scanning and proposes horizon scanning methods for pharmaceutical benefits management. The review results indicate that horizon scanning in Europe had different operational plans, such as the scope and duration of the search by country. However, the implementation typically aimed to reflect horizon scanning in policy decisions, such as determining benefits directions or establishing a regulatory agency management plan. Meanwhile, the results of horizon scanning in the United States and Korea were provided as reference materials to major stakeholders rather than directly reflecting them in the policy. Although listing high-priced drugs with uncertain long-term treatment effects and financial impact is expected to increase, periodic horizon scanning activities for pharmaceutical benefits management have not been conducted in Korea. Therefore, as a horizon scanning procedure for pharmaceutical benefits management, this study proposes the following four steps, namely, (step 1) define target indications and drug efficacy groups; (step 2) establish the purpose of horizon scanning; (step 3) review the extant literature; (step 4) summarize and discuss the results; (step 5) deliberate potential decision-making. KCI Citation Count: 0 |
| Author | Ssangeun Jo 변지혜 Ji-hye Byun 조쌍은 |
| Author_xml | – sequence: 1 fullname: 조쌍은 – sequence: 2 fullname: Ssangeun Jo – sequence: 3 fullname: 변지혜 – sequence: 4 fullname: Ji-hye Byun |
| BackLink | https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART003086804$$DAccess content in National Research Foundation of Korea (NRF) |
| BookMark | eNotj09LAkEAxYcwyMxzhy57Dnab_-MeRSoFIQjvw7i7U8uWxu6pW6AHPSWSZGGnKAjsllBgX2id_Q4tKY_He4cfD94uKHS6nQCAfQQdhl0iji7DWDmYOtRBTsC3QBELzmxBGClsOhec7oBykoRtyKAgGENYBHXzujTPD-ni07xMrdxm8puNB1b6PTSP8_TrbvU-X70tLTPrZ5OZZQbT7H6Y9UamN7SyaT97-rBWP_10MdoD21pdJUF5kyXQOjlu1ep28-y0Uas27YgxamOSi3sKVpSnPY4IIX7AK9jjKvCVFoFmkLcR0772KhRygqHLc5r6irexwKQEDteznVjLyAtlV4X_edGVUSyr562GRPk_FyOawwdrOAqTRN7E4bWKbyWFLoMIkT8EdXDn |
| ContentType | Journal Article |
| DBID | HZB Q5X ACYCR |
| DOI | 10.52937/hira.24.4.1.e6 |
| DatabaseName | 한국학술정보 KISS Korean Studies Information Service System (KISS) B-Type Korean Citation Index |
| DatabaseTitleList | |
| DeliveryMethod | fulltext_linktorsrc |
| DocumentTitleAlternate | 주요국의 의약품 급여관리를 위한 수평탐색 현황 비교 Comparison of Horizon Scanning Status for Pharmaceutical Benefits Management |
| EISSN | 2765-7353 |
| EndPage | 33 |
| ExternalDocumentID | oai_kci_go_kr_ARTI_10509214 4095011 |
| GroupedDBID | ALMA_UNASSIGNED_HOLDINGS HZB Q5X ACYCR |
| ID | FETCH-LOGICAL-k554-232326ca08acfc61333de682c6aedaf7ef506b15fdfc840632096a084da6b2723 |
| ISSN | 2765-6764 |
| IngestDate | Sun Jun 22 03:10:38 EDT 2025 Tue Dec 31 02:19:51 EST 2024 |
| IsPeerReviewed | false |
| IsScholarly | false |
| Issue | 1 |
| Language | Korean |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-k554-232326ca08acfc61333de682c6aedaf7ef506b15fdfc840632096a084da6b2723 |
| Notes | Health Insurance Review & Assessment Service https://www.hira-research.or.kr/journal/view.html?pn=current_issue&uid=955&vmd=Full |
| PageCount | 14 |
| ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_10509214 kiss_primary_4095011 |
| PublicationCentury | 2000 |
| PublicationDate | 20240531 |
| PublicationDateYYYYMMDD | 2024-05-31 |
| PublicationDate_xml | – month: 05 year: 2024 text: 20240531 day: 31 |
| PublicationDecade | 2020 |
| PublicationTitle | HIRA Research |
| PublicationTitleAlternate | HIRA Research |
| PublicationYear | 2024 |
| Publisher | 건강보험심사평가원 심사평가정책연구소 건강보험심사평가원 |
| Publisher_xml | – name: 건강보험심사평가원 심사평가정책연구소 – name: 건강보험심사평가원 |
| SSID | ssib050732200 ssib051086599 |
| Score | 1.8846096 |
| Snippet | With the recent development of innovative medical technology, the market entry of high-priced drugs, such as Kymriah, Zolgensma, and Luxturna injections, is... |
| SourceID | nrf kiss |
| SourceType | Open Website Publisher |
| StartPage | 20 |
| SubjectTerms | Decision support systems Emerging therapeutics Horizon scanning Insurance pharmaceutical Pharmaceutical policy services 사회학 |
| Title | 주요국의 의약품 급여관리를 위한 수평탐색 현황 비교 |
| URI | https://kiss.kstudy.com/ExternalLink/Ar?key=4095011 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART003086804 |
| Volume | 4 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | HIRA Research, 2024, 4(1), , pp.20-33 |
| journalDatabaseRights | – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2765-7353 dateEnd: 99991231 omitProxy: true ssIdentifier: ssib050732200 issn: 2765-6764 databaseCode: M~E dateStart: 20210101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1Na9RANNR68SJKFesXATunkphkZpLJMclu2Qr1ICv0tuRTy8JuWbcXDyJ0D92TRSyuUk-iINSbBYX6h3aT_-Cbl_1qKVKF3fDy5s3Me_OGmfcyM28UZYVFYZiYPNGSWKQaYzzURESpBl3Z4XYGYyIeH9t4bNeeskebfHPh0srcrqWdbqTHL889V_I_WgUc6FWekv0HzU4LBQTAoF94gobheSEdk2pAPEr8QAKuR1xGqh7xOfEqiKkQV6xOIQQ48SENXi0iZBqQCyJcTHOIFyCGyf0PVZ94NmIAgGxBWVJABMMCOMCIEgILrxCxhiUBQIlrYBIFzCqSi0k-l3gS5RPfRRQyXF7mObGSa-tPvOmeQNkJmAwnNffRAgU3iV9WAr-JvMKYkUANFAUBWgcBZMMN5r90WGyySD_um8iQKdtAAoaUsyzJL9l3xi0pfGwbACwEpuJjrrJa158IhkOt5djyCEYZT11PZziHcjo_vBtzhkIZwOPsFMTBfpKr4M-3OqFuMZ3ppp6eE-z7zCR8Ktx3M95qPGs3mp0GODXrDVPG6LHkbe2XgSlLXlCy8ao6GTXBoIdBeRZkkcu7szhenDoVq4xphaw9PM0YWCLgqLwAy6rVyeYsq_o15erYJVK9sn9fVxaa7SWlln8-yT--Gx5_zz8NVPjnB7-Lt3vq8Gc_f380_PF69PVo9OVEzQ97xcGhmu8Nijf9Ync_3-2rxaBXfPimjn71hsf7N5T6WrUe1LTxrR9aE0xbDSx88Cji0BBhnMVgbFKapLawYjtMkzBz0owbdmTyLMliAdYotcAJB2qWhHZkORa9qSy22q30lqJyizlGHJtmkpksDlMRCZrKdZA4pa7N6bKyJGVvbJdxXRoM3A2Y7paVB9AWqIS_KOP2hajuKFdmPfmustjt7KT3wIrtRvdRiX8Aj51_Ww |
| linkProvider | ISSN International Centre |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%EC%A3%BC%EC%9A%94%EA%B5%AD%EC%9D%98+%EC%9D%98%EC%95%BD%ED%92%88+%EA%B8%89%EC%97%AC%EA%B4%80%EB%A6%AC%EB%A5%BC+%EC%9C%84%ED%95%9C+%EC%88%98%ED%8F%89%ED%83%90%EC%83%89+%ED%98%84%ED%99%A9+%EB%B9%84%EA%B5%90&rft.jtitle=HIRA+Research%2C+4%281%29&rft.au=%EC%A1%B0%EC%8C%8D%EC%9D%80&rft.au=%EB%B3%80%EC%A7%80%ED%98%9C&rft.date=2024-05-31&rft.pub=%EA%B1%B4%EA%B0%95%EB%B3%B4%ED%97%98%EC%8B%AC%EC%82%AC%ED%8F%89%EA%B0%80%EC%9B%90&rft.issn=2765-6764&rft.eissn=2765-7353&rft.spage=20&rft.epage=33&rft_id=info:doi/10.52937%2Fhira.24.4.1.e6&rft.externalDBID=n%2Fa&rft.externalDocID=oai_kci_go_kr_ARTI_10509214 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2765-6764&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2765-6764&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2765-6764&client=summon |